Stereoselective oxidation metabolism of 20(S)-protopanaxatriol in human liver microsomes and in rats

References

• Chen G, Yang X, Zhai X, Yang M. (2013). Microbial transformation of 20(S)-protopanaxatriol by Absidia corymbifera and their cytotoxic activities against two human prostate cancer cell lines. Biotechnol Lett 35:91–5
   Google Scholar
• Chiu NT, Guns ES, Adomat H, et al. (2014). Identification of human cytochrome P450 enzymes involved in the hepatic and intestinal biotransformation of 20(S)-protopanaxadiol. Biopharm Drug Dispos 35:104–18
   PubMed Web of Science ®Google Scholar
• Evans DC, Baillie TA. (2005). Minimizing the potential for metabolic activation as an integral part of drug design. Curr Opin Drug Discov Devel 8:44–50
   PubMed Web of Science ®Google Scholar
• Han B, Meng Q, Li Q, et al. (2011). Effect of 20(S)-protopanaxatriol and its epimeric derivatives on myocardial injury induced by isoproterenol. Arzneimittelforschung 61:148–52
   Google Scholar
• Han KL, Jung MH, Sohn JH, Hwang JK. (2006). Ginsenoside 20S-protopanaxatriol (PPT) activates peroxisome proliferator-activated receptor gamma (PPARgamma) in 3T3-L1 adipocytes. Biol Pharm Bull 29:110–13
   PubMed Web of Science ®Google Scholar
• Hao H, Lai L, Zheng C, et al. (2010). Microsomal cytochrome P450-mediated metabolism of protopanaxatriol ginsenosides: metabolite profile, reaction phenotyping, and structure-metabolism relationship. Drug Metab Dispos 38:1731–9
   PubMed Web of Science ®Google Scholar
• Hasegawa E, Nakagawa S, Miyate Y, et al. (2013). Inhibitory effect of protopanaxatriol ginseng metabolite M4 on the production of corticosteroids in ACTH-stimulated bovine adrenal fasciculata cells. Life Sci 92:687–93
   Google Scholar
• Hasegawa H. (2004). Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J Pharmacol Sci 95:153–7
   PubMed Web of Science ®Google Scholar
• Hasegawa H, Sung JH, Matsumiya S, Uchiyama M. (1996). Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med 62:453–7
   PubMed Web of Science ®Google Scholar
• Hasegawa H, Suzuki R, Nagaoka T, et al. (2002). Prevention of growth and metastasis of murine melanoma through enhanced natural-killer cytotoxicity by fatty acid-conjugate of protopanaxatriol. Biol Pharm Bull 25:861–6
   PubMed Web of Science ®Google Scholar
• He C, Zhou D, Li J, et al. (2014). Identification of 20(S)-protopanaxatriol metabolites in rats by ultra-performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry and nuclear magnetic resonance spectroscopy. J Pharm Biomed Anal 88:497–508
   Google Scholar
• Kasai R, Hara K, Dokan R, et al. (2000). Major metabolites of ginseng sapogenins formed by rat liver microsomes. Chem Pharm Bull 48:1226–7
   PubMedGoogle Scholar
• Kong LT, Wang Q, Xiao BX, et al. (2013). Different pharmacokinetics of the two structurally similar dammarane sapogenins, protopanaxatriol and protopanaxadiol, in rats. Fitoterapia 86:48–53
   Google Scholar
• Lai L, Hao H, Liu Y, et al. (2009). Characterization of pharmacokinetic profiles and metabolic pathways of 20(S)-ginsenoside Rh1 in vivo and in vitro. Planta Med 75:797–802
   PubMed Web of Science ®Google Scholar
• Li L, Chen X, Li D, Zhong D. (2011). Identification of 20(S)-protopanaxadiol metabolites in human liver microsomes and human hepatocytes. Drug Metab Dispos 39:472–83
   PubMed Web of Science ®Google Scholar
• Li L, Chen X, Zhou J, Zhong D. (2012). In vitro studies on the oxidative metabolism of 20(s)-ginsenoside Rh2 in human, monkey, dog, rat, and mouse liver microsomes, and human liver S9. Drug Metab Dispos 40:2041–53
   Google Scholar
• Li XQ, Weidolf L, Simonsson R, Andersson TB. (2005). Enantiomer/enantiomer interactions between the S- and R- isomers of omeprazole in human cytochrome P450 enzymes: major role of CYP2C19 and CYP3A4. J Pharmacol Exp Ther 315:777–87
   PubMed Web of Science ®Google Scholar
• Liu L, Gu LJ, Zhang DL, et al. (2010). Microbial conversion of rare ginsenoside Rf to 20(S)-protopanaxatriol by Aspergillus niger. Biosci Biotechnol Biochem 74:96–100
   PubMed Web of Science ®Google Scholar
• Oh GS, Pae HO, Choi BM, et al. (2004). 20(S)-Protopanaxatriol, one of ginsenoside metabolites, inhibits inducible nitric oxide synthase and cyclooxygenase-2 expressions through inactivation of nuclear factor-kappaB in RAW 264.7 macrophages stimulated with lipopolysaccharide. Cancer Lett 205:23–9
   PubMed Web of Science ®Google Scholar
• Shibata S. (2001). Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J Korean Med Sci 16:28–37
   PubMed Web of Science ®Google Scholar
• Shimshoni JA, Roberts AG, Scian M, et al. (2012). Stereoselective formation and metabolism of 4-hydroxy-retinoic acid enantiomers by cytochrome p450 enzymes. J Biol Chem 287:42223–32
   PubMed Web of Science ®Google Scholar
• Sun J, Wang G, Haitang X, et al. (2005). Simultaneous rapid quantification of ginsenoside Rg1 and its secondary glycoside Rh1 and aglycone protopanaxatriol in rat plasma by liquid chromatography-mass spectrometry after solid-phase extraction. J Pharm Biomed Anal 38:126–32
   PubMed Web of Science ®Google Scholar
• Sun SY, Wang YQ, Li LP, et al. (2013). Stereoselective interaction between tetrahydropalmatine enantiomers and CYP enzymes in human liver microsomes. Chirality 251:43–7
   Google Scholar
• Tawab MA, Bahr U, Karas M, et al. (2003). Degradation of ginsenosides in humans after oral administration. Drug Metab Dispos 31:1065–71
   PubMed Web of Science ®Google Scholar
• Tian Y, Guo H, Han J, Guo D. (2005). Microbial transformation of 20(S)-protopanaxatriol by Mucor spinosus. J Nat Prod 68:678–80
   PubMed Web of Science ®Google Scholar
• Usami Y, Liu YN, Lin AS, et al. (2008). Antitumor agents. 261. 20(S)-protopanaxadiol and 20(s)-protopanaxatriol as antiangiogenic agents and total assignment of (1)H NMR spectra. J Nat Prod 71:478–81
   PubMed Web of Science ®Google Scholar
• Wang YZ, Chen J, Chu SF, et al. (2009). Improvement of memory in mice and increase of hippocampal excitability in rats by ginsenoside Rg1’s metabolites ginsenoside Rh1 and protopanaxatriol. J Pharmacol Sci 109:504–10
   PubMed Web of Science ®Google Scholar
• Wang YZ, Wang YS, Chu SF, et al. (2010). Protopanaxatriol metabolites identified by LC-MS/MS after oral administration in mice. Int J Clin Pharmacol Ther 48:282–90
   Google Scholar
• Zhang J, Guo H, Tian Y, et al. (2007). Biotransformation of 20(S)-protopanaxatriol by Mucor spinosus and the cytotoxic structure activity relationships of the transformed products. Phytochemistry 68:2523–30
   PubMed Web of Science ®Google Scholar